<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The diagnostic criteria for <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo> have been controversial since this disease was initially described </plain></SENT>
<SENT sid="1" pm="."><plain>Using the current World Health Organization classification criteria, we retrospectively reviewed cases of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> in which erythroid precursors were &gt;or=50% of the bone marrow nucleated cell population and the diagnosis of <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> was considered using older classification schemes </plain></SENT>
<SENT sid="2" pm="."><plain>We collected 90 cases and separated them into four diagnostic groups: <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> or erythroid/myeloid type (n=20); <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>-related changes (n=22); therapy-related <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (n=32); and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts and preceding or concurrent history of erythropoietin therapy for <z:hpo ids='HP_0001903'>anemia</z:hpo> (n=16) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo> were the youngest patient group and had the best overall survival </plain></SENT>
<SENT sid="4" pm="."><plain>There was a statistically significant difference in overall survival between patients with <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo> versus <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>-related changes (P=0.003) and between patients with <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo> versus therapy-related <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (P&lt;0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of complex cytogenetic abnormalities (&gt;3) was the only statistically significant independent variable that adversely affected survival in the <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo> group </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0004026'>Monosomy</z:mp> 5/del(5q) and <z:mp ids='MP_0004026'>monosomy</z:mp> 7/del(7q) were overrepresented in the context of complex chromosomal abnormalities </plain></SENT>
<SENT sid="7" pm="."><plain>Our data suggest that <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, as currently defined in the World Health Organization classification, has become a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>A majority of the cases reported previously as <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> are now classified as other entities </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, our data suggest that the current definition of <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> type remains <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>One subset of <z:hpo ids='HP_0011009'>acute</z:hpo> erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients has relatively low blast counts and are diploid </plain></SENT>
<SENT sid="11" pm="."><plain>The prognosis of this patient subset is relatively good </plain></SENT>
<SENT sid="12" pm="."><plain>The other subset has cytogenetic abnormalities similar to those in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and a poor prognosis </plain></SENT>
</text></document>